The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - MedImmune
Leadership - MedImmune
Stock and Other Ownership Interests - AstraZeneca
Honoraria - MedImmune
Travel, Accommodations, Expenses - MedImmune
A Phase 1 study to evaluate the safety, pharmacokinetics, immunogenicity, and antitumor activity of MEDI4276 in patients with select HER2-expressing advanced solid tumors.
 
Erika Paige Hamilton
No Relationships to Disclose
 
Manish R. Patel
Honoraria - Gilead Sciences; Medivation
Speakers' Bureau - Gilead Sciences; Medivation; Taiho Pharmaceutical
 
Mark D. Pegram
Employment - Dava Oncology (I)
Consulting or Advisory Role - Genenetech, Pfizer, Novartis, AstraZeneca
Expert Testimony - Novartis
Travel, Accommodations, Expenses - Genentech, Pfizer, Novartis
Other Relationship - Genentech, Pfizer, Novartis, AstraZeneca
 
Antoinette R. Tan
Research Funding - Abbvie (Inst); Bayer/Onyx (Inst); Eisai (Inst); Genentech (Inst); GlaxoSmithKline (Inst); ImClone Systems (Inst); Merck (Inst); Nektar (Inst)
 
Anna Maria Storniolo
Stock and Other Ownership Interests - Amgen (I); Celgene (I); Gilead Sciences (I)
Honoraria - Pfizer
 
John Li
Employment - MedImmune
Stock and Other Ownership Interests - AstraZeneca
Patents, Royalties, Other Intellectual Property - MedImmune
Travel, Accommodations, Expenses - MedImmune
 
Xiang-Qing Yu
Employment - MedImmune
Stock and Other Ownership Interests - MedImmune
 
Anita Scheuber
No Relationships to Disclose